chr6-152132218-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.26002-4A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00479 in 1,613,944 control chromosomes in the GnomAD database, including 304 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 144 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 160 hom. )

Consequence

SYNE1
NM_182961.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0004316
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -2.96

Publications

0 publications found
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
SYNE1 Gene-Disease associations (from GenCC):
  • autosomal recessive ataxia, Beauce type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Orphanet, PanelApp Australia, G2P
  • Emery-Dreifuss muscular dystrophy 4, autosomal dominant
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Illumina, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • arthrogryposis multiplex congenita 3, myogenic type
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive myogenic arthrogryposis multiplex congenita
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 6-152132218-T-C is Benign according to our data. Variant chr6-152132218-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 130432.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0836 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_182961.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SYNE1
NM_182961.4
MANE Select
c.26002-4A>G
splice_region intron
N/ANP_892006.3Q8NF91-1
SYNE1
NM_001347702.2
MANE Plus Clinical
c.2536-4A>G
splice_region intron
N/ANP_001334631.1F8WAI0
SYNE1
NM_033071.5
c.25858-4A>G
splice_region intron
N/ANP_149062.2Q8NF91-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SYNE1
ENST00000367255.10
TSL:1 MANE Select
c.26002-4A>G
splice_region intron
N/AENSP00000356224.5Q8NF91-1
SYNE1
ENST00000354674.5
TSL:5 MANE Plus Clinical
c.2536-4A>G
splice_region intron
N/AENSP00000346701.4F8WAI0
SYNE1
ENST00000423061.6
TSL:1
c.25858-4A>G
splice_region intron
N/AENSP00000396024.1A0A0C4DG40

Frequencies

GnomAD3 genomes
AF:
0.0250
AC:
3807
AN:
152162
Hom.:
145
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0863
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00982
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.0268
GnomAD2 exomes
AF:
0.00662
AC:
1664
AN:
251494
AF XY:
0.00469
show subpopulations
Gnomad AFR exome
AF:
0.0891
Gnomad AMR exome
AF:
0.00390
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.000652
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000369
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00269
AC:
3927
AN:
1461664
Hom.:
160
Cov.:
30
AF XY:
0.00236
AC XY:
1715
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.0910
AC:
3045
AN:
33456
American (AMR)
AF:
0.00487
AC:
218
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000191
AC:
5
AN:
26134
East Asian (EAS)
AF:
0.000403
AC:
16
AN:
39696
South Asian (SAS)
AF:
0.000185
AC:
16
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5768
European-Non Finnish (NFE)
AF:
0.000213
AC:
237
AN:
1111846
Other (OTH)
AF:
0.00608
AC:
367
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
177
354
530
707
884
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0250
AC:
3806
AN:
152280
Hom.:
144
Cov.:
32
AF XY:
0.0240
AC XY:
1786
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0860
AC:
3572
AN:
41538
American (AMR)
AF:
0.00980
AC:
150
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5174
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68028
Other (OTH)
AF:
0.0265
AC:
56
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
167
335
502
670
837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0182
Hom.:
56
Bravo
AF:
0.0287
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Autosomal recessive ataxia, Beauce type (1)
-
-
1
Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant (1)
-
-
1
Emery-Dreifuss muscular dystrophy 4, autosomal dominant (1)
-
-
1
SYNE1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.39
DANN
Benign
0.62
PhyloP100
-3.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00043
dbscSNV1_RF
Benign
0.030

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77220999; hg19: chr6-152453353; API